Artelo Biosciences, Inc.
ARTL
$1.95
$0.3018.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.12M | -3.22M | -2.37M | -3.78M | -1.13M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 83.00K | 54.00K | -- | -- | -- |
| Total Other Non-Cash Items | 366.00K | 159.00K | 200.00K | 176.00K | 154.00K |
| Change in Net Operating Assets | -827.00K | 2.49M | 575.00K | 1.04M | 200.00K |
| Cash from Operations | -3.50M | -514.00K | -1.60M | -2.57M | -778.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -250.00K | -- | -- | 500.00K | 4.25M |
| Cash from Investing | -250.00K | -- | -- | 500.00K | 4.25M |
| Total Debt Issued | 0.00 | 737.00K | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.44M | 1.08M | -- | 57.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.44M | 1.82M | -- | 57.00K | 0.00 |
| Foreign Exchange rate Adjustments | -42.00K | 18.00K | 5.00K | -9.00K | 4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -346.00K | 1.32M | -1.59M | -2.02M | 3.48M |